# A Novel Eye Tracking–Based Gamified Assessment of Contrast Sensitivity Function in Children: Prospective Development and Reliability Study

**Authors:** Yunsi He, Yijing Zhuang, Lei Feng, Xuanyu Xu, Ying Deng, Moruomi Li, Yangfei Pang, Ying Yao, Wentong Yu, Zixuan Xu, Yusong Zhou, Yudan Zhong, Qiuying Li, Qingqing Ye, Junpeng Yuan, Yun Wen, Jinrong Li

PMC · DOI: 10.2196/81082 · JMIR Serious Games · 2025-11-20

## TL;DR

A new eye-tracking game helps reliably measure vision in young children by making contrast sensitivity testing engaging and efficient.

## Contribution

A novel gamified eye-tracking tool for assessing contrast sensitivity in preschool children with improved efficiency and reliability.

## Key findings

- The ETGCSF tool showed strong reliability with ICCs of 0.89 for both AULCSF and CSF acuity in the baseline experiment.
- Optimized ETGCSF reduced test duration by half while maintaining comparable reliability in preschool children.
- The modular design of ETGCSF allows for future adaptations in clinical and research settings.

## Abstract

Reliable assessment of visual function in young children remains a challenge. Contrast sensitivity function (CSF) is a sensitive and fundamental index of visual performance, yet existing pediatric CSF assessments lack objectivity and adaptability. To bridge this methodological gap, we developed a novel eye tracking–based gamified contrast sensitivity function (ETGCSF) tool that integrates gaze-based detection with interactive gameplay to objectively quantify CSF in an engaging and child-centered manner.

This study aimed to (1) establish the feasibility and test-retest reliability of the ETGCSF tool in preschool-aged children and (2) evaluate whether optimization using adaptive algorithms and enhanced gamification elements could improve test efficiency while maintaining reliability.

This was a prospective study with 2 sequential cohorts. A total of 80 Chinese children aged 3 to 6 years were pragmatically recruited from Zhongshan Ophthalmic Center between May 2021 and July 2023. On the basis of timing of data collection, 35% (28/80) of the children were included in experiment 1 (mean age 5.24, SD 0.15 years), and 65% (52/80) were included in experiment 2 (mean age 4.76, SD 0.11 years). Children completed 2 runs of ETGCSF test. Experiment 1 used the baseline ETGCSF protocol, and experiment 2 used the optimized protocol. Primary outcomes were test-retest reliability of the area under the log contrast sensitivity function curve (AULCSF) and CSF acuity, reported as intraclass correlation coefficients (ICCs) with 95% CIs.

In experiment 1, the ETGCSF tool showed strong reliability, with ICCs of 0.890 (95% CI 0.741‐0.951) for AULCSF and 0.890 (95% CI 0.763‐0.949) for CSF acuity. The median test duration was 482 (IQR 451‐569) seconds. In experiment 2, the optimized ETGCSF reduced median test duration to 241 (IQR 189‐296) seconds (P<.001) while maintaining comparable reliability. AULCSF estimates varied by 0.03 log units across 2 runs (95% CI −0.51 to 0.57; t51=0.749; P=.46), with an ICC of 0.851 (95% CI 0.740‐0.914; P<.001) that was not significantly different from that of experiment 1 (z=0.660; P=.51). Similarly, CSF acuity estimates varied by 0.004 log units (95% CI –0.33 to 0.32; t51=0.192; P=.85), with an ICC of 0.832 (95% CI 0.708‐0.904; P<.001), also comparable to that of experiment 1 (z=–0.925; P=.36).

This study introduces a paradigm shift in pediatric visual assessment by leveraging objective eye tracking and gamified engagement to transform contrast sensitivity testing into a scalable, child-friendly process. The ETGCSF tool demonstrated strong reliability and markedly improved efficiency in assessing CSF in preschool children aged 3 to 6 years. These findings support ETGCSF as a promising tool for real-world clinical practice, and its modular design holds potential for future adaptations ranging from streamlined rapid screening in very young children to full CSF profiling for research.

## Full-text entities

- **Genes:** SFRP1 (secreted frizzled related protein 1) [NCBI Gene 6422] {aka FRP, FRP-1, FRP1, FrzA, SARP2}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}
- **Diseases:** visual deprivation (MESH:D012892), multiple sclerosis (MESH:D009103), Diabetic Retinopathy (MESH:D003930), neuro-ophthalmic disorders (MESH:C535922), AULCSF (MESH:D005119), Blinding Eye Diseases (MESH:D005128), attention lapses (MESH:D001289), nystagmus (MESH:D009759), fatigue (MESH:D005221), blepharoptosis (MESH:D001763), deficits in visual performance (MESH:D014786)
- **Chemicals:** Gabor (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12634006/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12634006/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12634006/full.md

---
Source: https://tomesphere.com/paper/PMC12634006